CoChat

Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Recent studies showed that nonnucleoside reverse transcriptase inhibitors (NNRTIs) have variable effects on dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT). Efavirenz, one of three NNRTIs currently used in highly active anti-retroviral therapy, enhances subunit dimerization. Sedimentation equilibrium experiments on each subunit and equimolar mixtures of both subunits were used to measure dissociation constants for the three coupled dimerization reactions of RT in the absence and presence of saturating concentrations of the drug. The dimerization constants of the p51/p51 homodimer, the p66/p66 homodimer, and the p66/p51 heterodimer increased 600-, 50-, and 25-fold, respectively, upon binding of efavirenz. The effects of NNRTIs on RT dimerization are consistent with a thermodynamic linkage between subunit association/dissociation and inhibitor binding. Analysis of crystal structures of the p66/p51 heterodimer reveals that efavirenz binding induces small structural changes at the dimer interface.

Overview

Integrity signals

Registry

Crossref · 10.1021/bi051915z

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 12 references

Research works printed but not linked: 31

  1. Le Grice S. F. J., 1991, EMBO J., 10
  2. Becerra S. P., 1991, Biochemistry 30, 11707−11719.
  3. Divita G., 1995, Biochemistry 34, 16337−16346.
  4. Lebowitz J., 1994, Protein Sci. 3, 1374−1382.
  5. Sluis-Cremer N., 2002, Mol. Pharmacol. 62, 398−405.
  6. Sluis-Cremer N., 2000, Biochemistry 39, 1427−1433.
  7. Mao C., 2000, Biochem. Pharmacol. 60, 1251−1265.
  8. Sluis-Cremer N., 2004, Curr. HIV Res. 2, 323−332.
  9. Borkow G., 1997, Biochemistry 36, 3179−3185.
  10. Tachedjian G., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
  11. Merluzzi V. J., 1990, Science 250, 1411−1413.
  12. Spence R. A., 1995, Science 267, 988−993.
  13. Kohlstaedt L. A., 1992, Science 256, 1783−1790.
  14. Ren J., 2000, Structure 8, 1089−1094.
  15. Le Grice S. F. J., 1995, Methods Enzymol. 262, 130−144.
  16. Gill S. C., 1989, Anal. Biochem. 182, 319−326.
  17. Ignatov M. E., 2005, Biochemistry 44, 5346−5356.
  18. Makhatadze G. I., 1990, Partial molar, 30
  19. Gekko K., 1981, Biochemistry 20, 4667−4676.
  20. Osbourne J. C., Jr., 1984, J. Biol. Chem., 259
  21. Lewis M. S., 2004, Methods Enzymol. 384, 232−242.
  22. Rodgers D. W., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
  23. Hsiou Y., 1996, Structure 4, 853−857.
  24. Holladay L. A., 1972, J. Biol. Chem., 247
  25. Rausch J. W., 2000, J. Biol. Chem., 275
  26. Rothwell P. J., 2003, Proc. Natl. Acad. Sci. U.S.A. 100, 1655−1660.
  27. Young S. D., 1995, Antimicrob. Agents Chemother. 39, 2602−2605.
  28. Maga G., 2000, Antimicrob. Agents Chemother. 44, 1186−1194.
  29. Tachedjian G., 2005, Bioinf., 60, 13
  30. Wang J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91
  31. Jacobo-Molina A., 1993, Proc. Natl. Acad. Sci. U.S.A. 90

Cited by

See all 60

Metadata

Authors
Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D.
Affiliations
Case Western Reserve University (US)
Corresponding author
Holladay, Leslie A.
Venue
Biochemistry
Published
2006-02-10
Volume
45
Issue
9
Pages
2779-2789
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2085882047
Cited by
59
References
12
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 1
FWCI
3.90
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01gm052263-08)
  • National Heart, Lung, and Blood Institute (HL07653, T32HL007653)
  • National Institute of General Medical Sciences (GM 52263)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
efavirenz, HIV-1 reverse transcriptase, non-nucleoside reverse transcriptase inhibitors, p66/p51 heterodimer, subunit dimerization, inhibitor binding, dissociation constant, antiretroviral therapy
MeSH terms
Alkynes, Binding Sites, Cyclopropanes, Kinetics, Oxazines, Protein Conformation, Structure-Activity Relationship, Thermodynamics, Reverse Transcriptase Inhibitors, Dimerization, Protein Subunits, Benzoxazines, HIV Reverse Transcriptase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase. https://app.cochat.ai/papers/10.1021/bi051915z
The paper
Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D. (2006). Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase. Biochemistry. https://doi.org/10.1021/bi051915z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.